Skip to main content
Premium Trial:

Request an Annual Quote

Genomed to Offer BGI's NIPT in Poland

NEW YORK (GenomeWeb) – BGI Europe and molecular diagnostics firm Genomed this week announced a partnership to offer BGI's non-invasive prenatal test in Poland.

The deal makes Genomed Poland's leading service provider of the test called NIFTY, the firms said. NIFTY detects the risk of certain genetic conditions, including Down syndrome, from as early as 10 weeks into the pregnancy.

The agreement, they said, advances the development of personalized medicine in Poland by introducing next-generation sequencing technology to common prenatal practice. Financial and other terms were not disclosed.

Warsaw, Poland-based Genomed was founded in 2008. According to its website, the firm has the widest genetic testing offering in the country.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.